Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice

被引：1
作者：
Jadvar, Hossein [1 ,2 ]
Iravani, Amir [3 ]
Bodei, Lisa [4 ]
Calais, Jeremie [5 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Div Nucl Med, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Mol Imaging Ctr, Keck Sch Med, Dept Radiol, Los Angeles, CA 90007 USA
[3] Univ Washington, Dept Radiol, Div Nucl Med, Seattle, WA USA
[4] Mem Sloan Kettering Canc Ctr, Dept Radiol, Mol Imaging & Therapy Serv, New York, NY USA
[5] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷 / 12期
关键词：
RESISTANT PROSTATE-CANCER; PROGRESSION-FREE SURVIVAL; PSMA PET/CT; 177LU-PSMA-617; MULTICENTER; SAFETY;
D O I：
10.2967/jnumed.124.268023
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：1851 / 1854
页数：4
相关论文
共 50 条
[31]   Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function [J].
Rosar, Florian ;
Kochems, Niklas ;
Bartholomae, Mark ;
Maus, Stephan ;
Stemler, Tobias ;
Linxweiler, Johannes ;
Khreish, Fadi ;
Ezziddin, Samer .
CANCERS, 2021, 13 (12)
[32]   Preparation of 177Lu-PSMA-617 in Hospital Radiopharmacy: Convenient Formulation of a Clinical Dose Using a Single-Vial Freeze-Dried PSMA-617 Kit Developed In-House [J].
Guleria, Mohini ;
Amirdhanayagam, Jeyachitra ;
Sarma, Haladhar D. ;
Rallapeta, Ramya Priya ;
Krishnamohan, V. S. ;
Nimmagadda, Ajit ;
Ravi, Parthasarathy ;
Patri, Sailaja ;
Kalawat, Tekchand ;
Das, Tapas .
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[33]   Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer: A Meta-analysis [J].
Kim, Yong Joong ;
Kim, Yong-il .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (10) :728-734
[34]   Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement [J].
Groener, Daniel ;
Baumgarten, Justus ;
Haefele, Sebastian ;
Happel, Christian ;
Klimek, Konrad ;
Mader, Nicolai ;
Ngoc, Christina Nguyen ;
Tselis, Nikolaos ;
Chun, Felix K. H. ;
Gruenwald, Frank ;
Sabet, Amir .
CANCERS, 2021, 13 (16)
[35]   Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial) [J].
Kuo, Phillip H. ;
Morris, Michael J. ;
Hesterman, Jacob ;
Kendi, A. Tuba ;
Rahbar, Kambiz ;
Wei, Xiao X. ;
Fang, Bruno ;
Adra, Nabil ;
Garje, Rohan ;
Michalski, Jeff M. ;
Chi, Kim ;
de Bono, Johann ;
Fizazi, Karim ;
Krause, Bernd ;
Sartor, Oliver ;
Tagawa, Scott T. ;
Ghebremariam, Samson ;
Brackman, Marcia ;
Wong, Connie C. ;
Catafau, Ana M. ;
Benson, Taylor ;
Armstrong, Andrew J. ;
Herrmann, Ken .
RADIOLOGY, 2024, 312 (02)
[36]   Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies [J].
Kuo, Hsiou-Ting ;
Merkens, Helen ;
Zhang, Zhengxing ;
Uribe, Carlos F. ;
Lau, Joseph ;
Zhang, Chengcheng ;
Colpo, Nadine ;
Lin, Kuo-Shyan ;
Benard, Francois .
MOLECULAR PHARMACEUTICS, 2018, 15 (11) :5183-5191
[37]   Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis [J].
Rosar, Florian ;
Krause, Jonas ;
Bartholoma, Mark ;
Maus, Stephan ;
Stemler, Tobias ;
Hierlmeier, Ina ;
Linxweiler, Johannes ;
Ezziddin, Samer ;
Khreish, Fadi .
PHARMACEUTICS, 2021, 13 (05)
[38]   EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) [J].
Kratochwil, Clemens ;
Fendler, Wolfgang Peter ;
Eiber, Matthias ;
Baum, Richard ;
Bozkurt, Murat Fani ;
Czernin, Johannes ;
Delgado Bolton, Roberto C. ;
Ezziddin, Samer ;
Forrer, Flavio ;
Hicks, Rodney J. ;
Hope, Thomas A. ;
Kabasakal, Levant ;
Konijnenberg, Mark ;
Kopka, Klaus ;
Lassmann, Michael ;
Mottaghy, Felix M. ;
Oyen, Wim ;
Rahbar, Kambiz ;
Schoder, Heiko ;
Virgolini, Irene ;
Wester, Hans-Juergen ;
Bodei, Lisa ;
Fanti, Stefano ;
Haberkorn, Uwe ;
Herrmann, Ken .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (12) :2536-2544
[39]   Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy [J].
Herrmann, Ken ;
Rahbar, Kambiz ;
Eiber, Matthias ;
Sparks, Richard ;
Baca, Nicholas ;
Krause, Bernd J. ;
Lassmann, Michael ;
Jentzen, Walter ;
Tang, Jun ;
Chicco, Daniela ;
Klein, Patrick ;
Blumenstein, Lars ;
Basque, Jean-Rene ;
Kurth, Jens .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) :71-78
[40]   Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) [J].
Kratochwil, Clemens ;
Fendler, Wolfgang P. ;
Eiber, Matthias ;
Hofman, Michael S. ;
Emmett, Louise ;
Calais, Jeremie ;
Osborne, Joseph R. ;
Iravani, Amir ;
Koo, Phillip ;
Lindenberg, Liza ;
Baum, Richard P. ;
Bozkurt, Murat Fani ;
Bolton, Roberto Delgado C. ;
Ezziddin, Samer ;
Forrer, Flavio ;
Hicks, Rodney J. ;
Hope, Thomas A. ;
Kabasakal, Levent ;
Konijnenberg, Mark ;
Kopka, Klaus ;
Lassmann, Michael ;
Mottaghy, Felix M. ;
Oyen, Wim J. G. ;
Rahbar, Kambiz ;
Schoder, Heiko ;
Virgolini, Irene ;
Bodei, Lisa ;
Fanti, Stefano ;
Haberkorn, Uwe ;
Hermann, Ken .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) :2830-2845
12345